| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | histone H3K4me/H3K4me2/H3K4me3 demethylase activity | 1.73e-05 | 6 | 22 | 2 | GO:0034647 | |
| GeneOntologyMolecularFunction | histone H3K4 demethylase activity | 3.23e-05 | 8 | 22 | 2 | GO:0032453 | |
| GeneOntologyMolecularFunction | histone H3 demethylase activity | 4.30e-04 | 28 | 22 | 2 | GO:0141052 | |
| GeneOntologyMolecularFunction | histone demethylase activity | 5.28e-04 | 31 | 22 | 2 | GO:0032452 | |
| GeneOntologyMolecularFunction | protein demethylase activity | 5.63e-04 | 32 | 22 | 2 | GO:0140457 | |
| GeneOntologyMolecularFunction | demethylase activity | 1.07e-03 | 44 | 22 | 2 | GO:0032451 | |
| GeneOntologyMolecularFunction | 2-oxoglutarate-dependent dioxygenase activity | 2.31e-03 | 65 | 22 | 2 | GO:0016706 | |
| GeneOntologyMolecularFunction | DNA-binding transcription factor activity, RNA polymerase II-specific | 3.45e-03 | 1412 | 22 | 6 | GO:0000981 | |
| GeneOntologyMolecularFunction | dioxygenase activity | 5.17e-03 | 98 | 22 | 2 | GO:0051213 | |
| GeneOntologyBiologicalProcess | endodermal digestive tract morphogenesis | 6.51e-06 | 4 | 22 | 2 | GO:0061031 | |
| GeneOntologyBiologicalProcess | heart morphogenesis | 1.87e-05 | 321 | 22 | 5 | GO:0003007 | |
| GeneOntologyBiologicalProcess | digestive tract morphogenesis | 3.29e-05 | 59 | 22 | 3 | GO:0048546 | |
| GeneOntologyBiologicalProcess | olfactory bulb interneuron development | 5.94e-05 | 11 | 22 | 2 | GO:0021891 | |
| GeneOntologyBiologicalProcess | neuron development | 8.17e-05 | 1463 | 22 | 8 | GO:0048666 | |
| GeneOntologyBiologicalProcess | branching morphogenesis of a nerve | 1.13e-04 | 15 | 22 | 2 | GO:0048755 | |
| GeneOntologyBiologicalProcess | negative regulation of apoptotic process | 1.22e-04 | 1133 | 22 | 7 | GO:0043066 | |
| GeneOntologyBiologicalProcess | eye development | 1.27e-04 | 480 | 22 | 5 | GO:0001654 | |
| GeneOntologyBiologicalProcess | visual system development | 1.31e-04 | 483 | 22 | 5 | GO:0150063 | |
| GeneOntologyBiologicalProcess | sensory system development | 1.41e-04 | 491 | 22 | 5 | GO:0048880 | |
| GeneOntologyBiologicalProcess | negative regulation of programmed cell death | 1.50e-04 | 1171 | 22 | 7 | GO:0043069 | |
| GeneOntologyBiologicalProcess | regulation of neurogenesis | 1.76e-04 | 515 | 22 | 5 | GO:0050767 | |
| GeneOntologyBiologicalProcess | embryonic digestive tract morphogenesis | 2.25e-04 | 21 | 22 | 2 | GO:0048557 | |
| GeneOntologyBiologicalProcess | positive regulation of axonogenesis | 2.35e-04 | 114 | 22 | 3 | GO:0050772 | |
| GeneOntologyBiologicalProcess | animal organ morphogenesis | 2.47e-04 | 1269 | 22 | 7 | GO:0009887 | |
| GeneOntologyBiologicalProcess | regulation of stem cell proliferation | 2.66e-04 | 119 | 22 | 3 | GO:0072091 | |
| GeneOntologyBiologicalProcess | axonogenesis | 2.73e-04 | 566 | 22 | 5 | GO:0007409 | |
| GeneOntologyBiologicalProcess | olfactory bulb interneuron differentiation | 3.48e-04 | 26 | 22 | 2 | GO:0021889 | |
| GeneOntologyBiologicalProcess | regulation of nervous system development | 4.31e-04 | 625 | 22 | 5 | GO:0051960 | |
| GeneOntologyBiologicalProcess | axon development | 4.88e-04 | 642 | 22 | 5 | GO:0061564 | |
| GeneOntologyBiologicalProcess | positive regulation of neurogenesis | 4.89e-04 | 354 | 22 | 4 | GO:0050769 | |
| GeneOntologyBiologicalProcess | digestive tract development | 5.45e-04 | 152 | 22 | 3 | GO:0048565 | |
| GeneOntologyBiologicalProcess | stem cell proliferation | 5.88e-04 | 156 | 22 | 3 | GO:0072089 | |
| GeneOntologyBiologicalProcess | embryonic digestive tract development | 6.33e-04 | 35 | 22 | 2 | GO:0048566 | |
| GeneOntologyBiologicalProcess | cardiac chamber morphogenesis | 6.45e-04 | 161 | 22 | 3 | GO:0003206 | |
| GeneOntologyBiologicalProcess | positive regulation of mesenchymal cell proliferation | 6.69e-04 | 36 | 22 | 2 | GO:0002053 | |
| GeneOntologyBiologicalProcess | digestive system development | 7.17e-04 | 167 | 22 | 3 | GO:0055123 | |
| GeneOntologyBiologicalProcess | smoothened signaling pathway | 8.35e-04 | 176 | 22 | 3 | GO:0007224 | |
| GeneOntologyBiologicalProcess | sensory organ development | 8.74e-04 | 730 | 22 | 5 | GO:0007423 | |
| GeneOntologyBiologicalProcess | positive regulation of nervous system development | 9.10e-04 | 418 | 22 | 4 | GO:0051962 | |
| GeneOntologyBiologicalProcess | cell morphogenesis involved in neuron differentiation | 9.75e-04 | 748 | 22 | 5 | GO:0048667 | |
| GeneOntologyBiologicalProcess | camera-type eye development | 9.77e-04 | 426 | 22 | 4 | GO:0043010 | |
| GeneOntologyBiologicalProcess | lens fiber cell differentiation | 1.00e-03 | 44 | 22 | 2 | GO:0070306 | |
| GeneOntologyBiologicalProcess | heart development | 1.03e-03 | 757 | 22 | 5 | GO:0007507 | |
| GeneOntologyBiologicalProcess | neural tube patterning | 1.05e-03 | 45 | 22 | 2 | GO:0021532 | |
| GeneOntologyBiologicalProcess | regulation of mesenchymal cell proliferation | 1.05e-03 | 45 | 22 | 2 | GO:0010464 | |
| GeneOntologyBiologicalProcess | regulation of axonogenesis | 1.07e-03 | 192 | 22 | 3 | GO:0050770 | |
| GeneOntologyBiologicalProcess | cell morphogenesis | 1.24e-03 | 1194 | 22 | 6 | GO:0000902 | |
| GeneOntologyBiologicalProcess | neuron projection morphogenesis | 1.33e-03 | 802 | 22 | 5 | GO:0048812 | |
| GeneOntologyBiologicalProcess | cardiac chamber development | 1.43e-03 | 212 | 22 | 3 | GO:0003205 | |
| GeneOntologyBiologicalProcess | olfactory bulb development | 1.45e-03 | 53 | 22 | 2 | GO:0021772 | |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection morphogenesis | 1.46e-03 | 819 | 22 | 5 | GO:0120039 | |
| GeneOntologyBiologicalProcess | growth | 1.48e-03 | 1235 | 22 | 6 | GO:0040007 | |
| GeneOntologyBiologicalProcess | cell projection morphogenesis | 1.52e-03 | 826 | 22 | 5 | GO:0048858 | |
| GeneOntologyBiologicalProcess | olfactory lobe development | 1.62e-03 | 56 | 22 | 2 | GO:0021988 | |
| GeneOntologyBiologicalProcess | ventricular septum morphogenesis | 1.62e-03 | 56 | 22 | 2 | GO:0060412 | |
| GeneOntologyBiologicalProcess | positive regulation of cell projection organization | 1.69e-03 | 494 | 22 | 4 | GO:0031346 | |
| GeneOntologyBiologicalProcess | mesenchymal cell proliferation | 1.79e-03 | 59 | 22 | 2 | GO:0010463 | |
| GeneOntologyBiologicalProcess | neuron projection development | 1.81e-03 | 1285 | 22 | 6 | GO:0031175 | |
| GeneOntologyBiologicalProcess | regulation of morphogenesis of a branching structure | 2.17e-03 | 65 | 22 | 2 | GO:0060688 | |
| GeneOntologyBiologicalProcess | developmental growth | 2.34e-03 | 911 | 22 | 5 | GO:0048589 | |
| GeneOntologyBiologicalProcess | positive regulation of stem cell proliferation | 2.65e-03 | 72 | 22 | 2 | GO:2000648 | |
| GeneOntologyBiologicalProcess | positive regulation of transcription by RNA polymerase II | 2.71e-03 | 1390 | 22 | 6 | GO:0045944 | |
| GeneOntologyBiologicalProcess | heart valve development | 3.11e-03 | 78 | 22 | 2 | GO:0003170 | |
| GeneOntologyBiologicalProcess | animal organ formation | 3.11e-03 | 78 | 22 | 2 | GO:0048645 | |
| GeneOntologyBiologicalProcess | receptor metabolic process | 3.43e-03 | 82 | 22 | 2 | GO:0043112 | |
| GeneOntologyBiologicalProcess | regulation of neuron projection development | 3.67e-03 | 612 | 22 | 4 | GO:0010975 | |
| GeneOntologyBiologicalProcess | positive regulation of cell development | 3.71e-03 | 614 | 22 | 4 | GO:0010720 | |
| GeneOntologyBiologicalProcess | developmental growth involved in morphogenesis | 3.79e-03 | 299 | 22 | 3 | GO:0060560 | |
| GeneOntologyBiologicalProcess | ovarian follicle development | 3.85e-03 | 87 | 22 | 2 | GO:0001541 | |
| GeneOntologyCellularComponent | chromatin | 8.06e-05 | 1480 | 22 | 8 | GO:0000785 | |
| HumanPheno | Corneal perforation | 4.85e-06 | 3 | 7 | 2 | HP:0100583 | |
| Domain | Lys_sp_deMease-like_dom | 7.94e-06 | 4 | 22 | 2 | IPR013637 | |
| Domain | PLU-1 | 7.94e-06 | 4 | 22 | 2 | PF08429 | |
| Domain | zf-C5HC2 | 1.32e-05 | 5 | 22 | 2 | PF02928 | |
| Domain | Znf_C5HC2 | 1.32e-05 | 5 | 22 | 2 | IPR004198 | |
| Domain | JmjN | 5.93e-05 | 10 | 22 | 2 | PF02375 | |
| Domain | JmjN | 5.93e-05 | 10 | 22 | 2 | SM00545 | |
| Domain | JMJN | 5.93e-05 | 10 | 22 | 2 | PS51183 | |
| Domain | JmjN | 5.93e-05 | 10 | 22 | 2 | IPR003349 | |
| Domain | - | 1.38e-04 | 15 | 22 | 2 | 1.10.150.60 | |
| Domain | ARID | 1.38e-04 | 15 | 22 | 2 | PF01388 | |
| Domain | BRIGHT | 1.38e-04 | 15 | 22 | 2 | SM00501 | |
| Domain | ARID_dom | 1.38e-04 | 15 | 22 | 2 | IPR001606 | |
| Domain | ARID | 1.38e-04 | 15 | 22 | 2 | PS51011 | |
| Domain | JmjC | 3.60e-04 | 24 | 22 | 2 | PF02373 | |
| Domain | JMJC | 6.43e-04 | 32 | 22 | 2 | PS51184 | |
| Domain | JmjC_dom | 6.43e-04 | 32 | 22 | 2 | IPR003347 | |
| Domain | JmjC | 6.84e-04 | 33 | 22 | 2 | SM00558 | |
| Domain | Zinc_finger_PHD-type_CS | 2.63e-03 | 65 | 22 | 2 | IPR019786 | |
| Domain | PHD | 3.49e-03 | 75 | 22 | 2 | PF00628 | |
| Domain | Znf_PHD-finger | 3.86e-03 | 79 | 22 | 2 | IPR019787 | |
| Domain | PHD | 4.87e-03 | 89 | 22 | 2 | SM00249 | |
| Domain | Znf_PHD | 5.09e-03 | 91 | 22 | 2 | IPR001965 | |
| Domain | ZF_PHD_2 | 5.53e-03 | 95 | 22 | 2 | PS50016 | |
| Domain | ZF_PHD_1 | 5.65e-03 | 96 | 22 | 2 | PS01359 | |
| Domain | - | 8.56e-03 | 119 | 22 | 2 | 3.40.50.1820 | |
| Domain | AB_hydrolase | 8.56e-03 | 119 | 22 | 2 | IPR029058 | |
| Domain | TPR | 9.99e-03 | 129 | 22 | 2 | SM00028 | |
| Domain | TPR_repeat | 1.06e-02 | 133 | 22 | 2 | IPR019734 | |
| Pubmed | 3.82e-07 | 2 | 22 | 2 | 32081420 | ||
| Pubmed | Analysis of mutation rates in the SMCY/SMCX genes shows that mammalian evolution is male driven. | 3.82e-07 | 2 | 22 | 2 | 9060413 | |
| Pubmed | Mouse H-Y encoding Smcy gene and its X chromosomal homolog Smcx. | 3.82e-07 | 2 | 22 | 2 | 10441747 | |
| Pubmed | Inefficient purifying selection: the mammalian Y chromosome in the rodent genus Mus. | 3.82e-07 | 2 | 22 | 2 | 16416087 | |
| Pubmed | 3.82e-07 | 2 | 22 | 2 | 7524912 | ||
| Pubmed | Identification of a mouse male-specific transplantation antigen, H-Y. | 1.15e-06 | 3 | 22 | 2 | 7544442 | |
| Pubmed | Novel JARID1C/SMCX mutations in patients with X-linked mental retardation. | 2.29e-06 | 4 | 22 | 2 | 16541399 | |
| Pubmed | 2.29e-06 | 4 | 22 | 2 | 32732223 | ||
| Pubmed | 2.29e-06 | 4 | 22 | 2 | 7951230 | ||
| Pubmed | 2.29e-06 | 4 | 22 | 2 | 17320160 | ||
| Pubmed | Regional regulation of palatal growth and patterning along the anterior-posterior axis in mice. | 2.29e-06 | 4 | 22 | 2 | 16313398 | |
| Pubmed | 3.82e-06 | 5 | 22 | 2 | 8855241 | ||
| Pubmed | Shox2-deficient mice exhibit a rare type of incomplete clefting of the secondary palate. | 8.01e-06 | 7 | 22 | 2 | 16141225 | |
| Pubmed | 1.07e-05 | 8 | 22 | 2 | 24122442 | ||
| Pubmed | A census of human transcription factors: function, expression and evolution. | 1.62e-05 | 908 | 22 | 6 | 19274049 | |
| Pubmed | 2.09e-05 | 11 | 22 | 2 | 24812002 | ||
| Pubmed | 2.09e-05 | 11 | 22 | 2 | 30913328 | ||
| Pubmed | Fyn and argonaute 2 participate in maternal-mRNA degradation during mouse oocyte maturation. | 2.97e-05 | 13 | 22 | 2 | 35104175 | |
| Pubmed | 2.97e-05 | 13 | 22 | 2 | 24619213 | ||
| Pubmed | 2.97e-05 | 13 | 22 | 2 | 14660691 | ||
| Pubmed | A Sprouty4 reporter to monitor FGF/ERK signaling activity in ESCs and mice. | 2.97e-05 | 13 | 22 | 2 | 29964027 | |
| Pubmed | 3.46e-05 | 14 | 22 | 2 | 28552557 | ||
| Pubmed | 3.46e-05 | 14 | 22 | 2 | 18948418 | ||
| Pubmed | The septum transversum mesenchyme induces gall bladder development. | 3.99e-05 | 15 | 22 | 2 | 23951403 | |
| Pubmed | Evolutionary strata on the mouse X chromosome correspond to strata on the human X chromosome. | 3.99e-05 | 15 | 22 | 2 | 14762062 | |
| Pubmed | FGF8 Signaling Alters the Osteogenic Cell Fate in the Hard Palate. | 5.16e-05 | 17 | 22 | 2 | 29342370 | |
| Pubmed | Fibroblast growth factor receptor signaling is essential for lens fiber cell differentiation. | 5.16e-05 | 17 | 22 | 2 | 18455718 | |
| Pubmed | 5.81e-05 | 18 | 22 | 2 | 12682014 | ||
| Pubmed | Sex differences in sex chromosome gene expression in mouse brain. | 5.81e-05 | 18 | 22 | 2 | 12023983 | |
| Pubmed | Midline radial glia translocation and corpus callosum formation require FGF signaling. | 5.81e-05 | 18 | 22 | 2 | 16715082 | |
| Pubmed | Wntless is required for peripheral lung differentiation and pulmonary vascular development. | 7.21e-05 | 20 | 22 | 2 | 23523683 | |
| Pubmed | 9.59e-05 | 23 | 22 | 2 | 21223962 | ||
| Pubmed | Dlg5 maintains apical aPKC and regulates progenitor differentiation during lung morphogenesis. | 1.33e-04 | 27 | 22 | 2 | 23466739 | |
| Pubmed | 1.43e-04 | 28 | 22 | 2 | 19782673 | ||
| Pubmed | Crk proteins transduce FGF signaling to promote lens fiber cell elongation. | 1.76e-04 | 31 | 22 | 2 | 29360039 | |
| Pubmed | An atlas of combinatorial transcriptional regulation in mouse and man. | 1.86e-04 | 877 | 22 | 5 | 20211142 | |
| Pubmed | Multiplexed barcoded CRISPR-Cas9 screening enabled by CombiGEM. | 1.99e-04 | 33 | 22 | 2 | 26864203 | |
| Pubmed | Robo signalling controls pancreatic progenitor identity by regulating Tead transcription factors. | 2.12e-04 | 34 | 22 | 2 | 30504829 | |
| Pubmed | 2.24e-04 | 35 | 22 | 2 | 21074523 | ||
| Pubmed | WNT/RYK signaling restricts goblet cell differentiation during lung development and repair. | 3.24e-04 | 42 | 22 | 2 | 31776260 | |
| Pubmed | NANOG initiates epiblast fate through the coordination of pluripotency genes expression. | 3.89e-04 | 46 | 22 | 2 | 35729116 | |
| Pubmed | 4.16e-04 | 233 | 22 | 3 | 37704626 | ||
| Pubmed | 4.41e-04 | 49 | 22 | 2 | 34368113 | ||
| Pubmed | Novel interactive partners of neuroligin 3: new aspects for pathogenesis of autism. | 5.36e-04 | 54 | 22 | 2 | 25464930 | |
| Pubmed | 5.97e-04 | 57 | 22 | 2 | 18022353 | ||
| Cytoband | 19q13.3 | 7.11e-04 | 82 | 22 | 2 | 19q13.3 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr19p13 | 6.28e-03 | 797 | 22 | 3 | chr19p13 | |
| GeneFamily | AT-rich interaction domain containing | 1.09e-04 | 15 | 19 | 2 | 418 | |
| GeneFamily | PHD finger proteins|Lysine demethylases | 2.85e-04 | 24 | 19 | 2 | 485 | |
| GeneFamily | PHD finger proteins | 3.97e-03 | 90 | 19 | 2 | 88 | |
| GeneFamily | PRD class homeoboxes and pseudogenes | 4.14e-03 | 92 | 19 | 2 | 521 | |
| Coexpression | GSE16266_CTRL_VS_LPS_STIM_MEF_DN | 2.16e-05 | 200 | 22 | 4 | M7212 | |
| Computational | Pol II transcription. | 1.76e-04 | 71 | 17 | 3 | MODULE_308 | |
| Drug | Piperine [94-62-2]; Down 200; 14uM; PC3; HT_HG-U133A | 3.12e-05 | 191 | 22 | 4 | 4247_DN | |
| Drug | Flunisolide [3385-03-3]; Up 200; 9.2uM; PC3; HT_HG-U133A | 3.18e-05 | 192 | 22 | 4 | 4303_UP | |
| Drug | Dentacolor | 3.20e-05 | 9 | 22 | 2 | CID003035662 | |
| Drug | Simvastatin [79902-63-9]; Down 200; 9.6uM; PC3; HT_HG-U133A | 3.31e-05 | 194 | 22 | 4 | 4244_DN | |
| Drug | Metaproterenol sulfate, orciprenaline sulfate [5874-97-5]; Down 200; 7.6uM; PC3; HT_HG-U133A | 3.31e-05 | 194 | 22 | 4 | 4248_DN | |
| Drug | Doxylamine succinate [562-10-7]; Down 200; 10.2uM; PC3; HT_HG-U133A | 3.38e-05 | 195 | 22 | 4 | 4235_DN | |
| Drug | Sulfabenzamide [127-71-9]; Down 200; 14.4uM; MCF7; HT_HG-U133A | 3.59e-05 | 198 | 22 | 4 | 4979_DN | |
| Drug | Theophylline monohydrate [5967-84-0]; Down 200; 20.2uM; PC3; HT_HG-U133A | 3.66e-05 | 199 | 22 | 4 | 4228_DN | |
| Drug | silicon carbide | 5.85e-05 | 12 | 22 | 2 | CID000009863 | |
| Drug | soman | 9.30e-05 | 92 | 22 | 3 | CID000007305 | |
| Drug | MGA-100 | 1.35e-04 | 18 | 22 | 2 | CID000018020 | |
| Drug | dichloromethanediamine | 1.38e-04 | 539 | 22 | 5 | CID005311048 | |
| Drug | Super-Bond | 1.51e-04 | 19 | 22 | 2 | CID000123788 | |
| Drug | biperiden | 2.23e-04 | 23 | 22 | 2 | CID000002381 | |
| Drug | AZFd | 2.23e-04 | 23 | 22 | 2 | CID000196489 | |
| Drug | Q-MS | 2.86e-04 | 26 | 22 | 2 | CID000151506 | |
| Drug | zinc phosphate | 3.08e-04 | 27 | 22 | 2 | CID000024519 | |
| Drug | pseudohypericin | 3.08e-04 | 27 | 22 | 2 | CID005281751 | |
| Drug | AC1O3R20 | 3.32e-04 | 28 | 22 | 2 | CID006335051 | |
| Drug | muscarine | 3.49e-04 | 144 | 22 | 3 | CID000009308 | |
| Drug | AC1NRAS8 | 4.34e-04 | 32 | 22 | 2 | CID005288068 | |
| Drug | trihexyphenidyl | 4.34e-04 | 32 | 22 | 2 | CID000005572 | |
| Drug | anti-K | 4.62e-04 | 33 | 22 | 2 | CID000005337 | |
| Drug | Te Al | 5.20e-04 | 35 | 22 | 2 | CID000168005 | |
| Drug | iBVE | 5.50e-04 | 36 | 22 | 2 | CID000007992 | |
| Drug | digoxigenine | 6.80e-04 | 40 | 22 | 2 | CID000015478 | |
| Drug | thioflavin | 6.80e-04 | 40 | 22 | 2 | CID000022251 | |
| Drug | acrylic acid | 7.14e-04 | 41 | 22 | 2 | CID000006581 | |
| Drug | troglitazone; Up 200; 10uM; MCF7; HT_HG-U133A_EA | 7.48e-04 | 187 | 22 | 3 | 1070_UP | |
| Drug | Mepenzolate bromide [76-90-4]; Up 200; 9.6uM; PC3; HT_HG-U133A | 7.72e-04 | 189 | 22 | 3 | 4304_UP | |
| Drug | 17-AAG; Down 200; 1uM; HL60; HT_HG-U133A | 7.96e-04 | 191 | 22 | 3 | 2678_DN | |
| Drug | wortmannin from Penicillium funiculosum; Down 200; 0.01uM; HL60; HT_HG-U133A | 8.08e-04 | 192 | 22 | 3 | 2703_DN | |
| Drug | Deltaline [6836-11-9]; Up 200; 7.8uM; PC3; HT_HG-U133A | 8.20e-04 | 193 | 22 | 3 | 4306_UP | |
| Drug | Trimethylcolchicinic acid [3482-37-9]; Down 200; 11.6uM; PC3; HT_HG-U133A | 8.20e-04 | 193 | 22 | 3 | 4202_DN | |
| Drug | Cefalonium [5575-21-3]; Down 200; 8.8uM; PC3; HT_HG-U133A | 8.20e-04 | 193 | 22 | 3 | 4245_DN | |
| Drug | Letrozole [112809-51-5]; Down 200; 14uM; PC3; HT_HG-U133A | 8.20e-04 | 193 | 22 | 3 | 4240_DN | |
| Drug | Amprolium hydrochloride [137-88-2]; Down 200; 12.6uM; PC3; HT_HG-U133A | 8.20e-04 | 193 | 22 | 3 | 4241_DN | |
| Drug | Isoxsuprine hydrochloride [579-56-6]; Down 200; 11.8uM; PC3; HT_HG-U133A | 8.20e-04 | 193 | 22 | 3 | 4205_DN | |
| Drug | Midodrine hydrochloride [3092-17-9]; Down 200; 13.8uM; PC3; HT_HG-U133A | 8.32e-04 | 194 | 22 | 3 | 2087_DN | |
| Drug | Fludrocortisone acetate [514-36-3]; Down 200; 9.4uM; MCF7; HT_HG-U133A | 8.32e-04 | 194 | 22 | 3 | 3977_DN | |
| Drug | Indoprofen [31842-01-0]; Down 200; 14.2uM; PC3; HT_HG-U133A | 8.32e-04 | 194 | 22 | 3 | 4249_DN | |
| Drug | Clofilium tosylate [92953-10-1]; Down 200; 7.8uM; PC3; HT_HG-U133A | 8.32e-04 | 194 | 22 | 3 | 4492_DN | |
| Drug | 0317956-0000 [391210-11-0]; Down 200; 10uM; PC3; HT_HG-U133A | 8.32e-04 | 194 | 22 | 3 | 4331_DN | |
| Drug | Isradipine [75695-93-1]; Down 200; 10.8uM; PC3; HT_HG-U133A | 8.32e-04 | 194 | 22 | 3 | 6347_DN | |
| Drug | Cephalosporanic acid, 7-amino [957-68-6]; Down 200; 14.6uM; PC3; HT_HG-U133A | 8.32e-04 | 194 | 22 | 3 | 4242_DN | |
| Drug | Phensuximide [86-34-0]; Down 200; 21.2uM; MCF7; HT_HG-U133A | 8.32e-04 | 194 | 22 | 3 | 3521_DN | |
| Drug | Isotretinoin | 8.42e-04 | 799 | 22 | 5 | ctd:D015474 | |
| Drug | Benfotiamine [22457-89-2]; Up 200; 8.6uM; PC3; HT_HG-U133A | 8.45e-04 | 195 | 22 | 3 | 4312_UP | |
| Drug | Atovaquone [95233-18-4]; Down 200; 11uM; PC3; HT_HG-U133A | 8.45e-04 | 195 | 22 | 3 | 4201_DN | |
| Drug | Isoniazid [54-85-3]; Down 200; 29.2uM; PC3; HT_HG-U133A | 8.45e-04 | 195 | 22 | 3 | 5840_DN | |
| Drug | Chlorpromazine hydrochloride [69-09-0]; Down 200; 11.2uM; MCF7; HT_HG-U133A | 8.45e-04 | 195 | 22 | 3 | 1700_DN | |
| Drug | estradiol, USP; Down 200; 0.01uM; HL60; HT_HG-U133A | 8.45e-04 | 195 | 22 | 3 | 2701_DN | |
| Drug | Gentamicine sulfate [1405-41-0]; Down 200; 2.6uM; MCF7; HT_HG-U133A | 8.45e-04 | 195 | 22 | 3 | 2245_DN | |
| Drug | Sulfachloropyridazine [80-32-0]; Down 200; 14uM; PC3; HT_HG-U133A | 8.45e-04 | 195 | 22 | 3 | 4326_DN | |
| Drug | Propofol [2078-54-8]; Down 200; 22.4uM; PC3; HT_HG-U133A | 8.45e-04 | 195 | 22 | 3 | 6707_DN | |
| Drug | Carbachol [51-83-2]; Up 200; 21.8uM; HL60; HT_HG-U133A | 8.58e-04 | 196 | 22 | 3 | 3042_UP | |
| Drug | haloperidol; Down 200; 10uM; MCF7; HT_HG-U133A | 8.58e-04 | 196 | 22 | 3 | 1628_DN | |
| Drug | Seneciphylline [480-81-9]; Down 200; 12uM; PC3; HT_HG-U133A | 8.58e-04 | 196 | 22 | 3 | 4238_DN | |
| Drug | D-cycloserine [68-41-7]; Down 200; 39.2uM; MCF7; HT_HG-U133A | 8.58e-04 | 196 | 22 | 3 | 6782_DN | |
| Drug | Rapamycin; Down 200; 0.1uM; HL60; HT_HG-U133A | 8.58e-04 | 196 | 22 | 3 | 2667_DN | |
| Drug | N-WB | 8.60e-04 | 45 | 22 | 2 | CID000091419 | |
| Drug | procyanidin B2 | 8.60e-04 | 45 | 22 | 2 | CID000122738 | |
| Drug | Furaltadone hydrochloride [3759-92-0]; Up 200; 11uM; MCF7; HT_HG-U133A | 8.70e-04 | 197 | 22 | 3 | 3413_UP | |
| Drug | Dimethisoquin hydrochloride [2773-92-4]; Down 200; 13uM; PC3; HT_HG-U133A | 8.70e-04 | 197 | 22 | 3 | 4207_DN | |
| Drug | 2-propylpentanoic acid; Down 200; 200uM; MCF7; HT_HG-U133A | 8.70e-04 | 197 | 22 | 3 | 5211_DN | |
| Drug | 17-DMAG; Down 200; 0.1uM; HL60; HT_HG-U133A | 8.70e-04 | 197 | 22 | 3 | 2673_DN | |
| Drug | Trichlormethiazide [133-67-5]; Down 200; 10.6uM; HL60; HT_HG-U133A | 8.70e-04 | 197 | 22 | 3 | 2998_DN | |
| Drug | Cyanocobalamin [68-19-9]; Up 200; 3uM; HL60; HT_HG-U133A | 8.70e-04 | 197 | 22 | 3 | 1315_UP | |
| Drug | Pentolinium bitartrate [52-62-0]; Down 200; 7.4uM; MCF7; HT_HG-U133A | 8.70e-04 | 197 | 22 | 3 | 4699_DN | |
| Drug | Chlorhexidine [55-56-1]; Up 200; 8uM; PC3; HG-U133A | 8.83e-04 | 198 | 22 | 3 | 1942_UP | |
| Drug | SC 19220; Down 200; 10uM; PC3; HT_HG-U133A | 8.83e-04 | 198 | 22 | 3 | 7095_DN | |
| Drug | genistein; Down 200; 10uM; MCF7; HT_HG-U133A_EA | 8.83e-04 | 198 | 22 | 3 | 1073_DN | |
| Drug | Mianserine hydrochloride [21535-47-7]; Down 200; 13.2uM; PC3; HT_HG-U133A | 8.83e-04 | 198 | 22 | 3 | 2068_DN | |
| Drug | Butylparaben [94-26-8]; Down 200; 20.6uM; MCF7; HT_HG-U133A | 8.83e-04 | 198 | 22 | 3 | 6446_DN | |
| Drug | Midecamycin [35457-80-8]; Down 200; 5uM; MCF7; HT_HG-U133A | 8.83e-04 | 198 | 22 | 3 | 5345_DN | |
| Drug | 2-propylpentanoic acid; Down 200; 500uM; MCF7; HT_HG-U133A_EA | 8.83e-04 | 198 | 22 | 3 | 1020_DN | |
| Drug | Roxarsone [121-19-7]; Down 200; 15.2uM; MCF7; HT_HG-U133A | 8.83e-04 | 198 | 22 | 3 | 5470_DN | |
| Drug | Canavanine sulfate monohydrate (L,+) [206996-57-8]; Up 200; 13.6uM; MCF7; HT_HG-U133A | 8.83e-04 | 198 | 22 | 3 | 4782_UP | |
| Drug | rosiglitazone; Down 200; 10uM; HL60; HT_HG-U133A | 8.96e-04 | 199 | 22 | 3 | 2693_DN | |
| Drug | Isoxicam [34552-84-6]; Up 200; 12uM; HL60; HT_HG-U133A | 8.96e-04 | 199 | 22 | 3 | 1862_UP | |
| Drug | Disulfiram [97-77-8]; Down 200; 13.4uM; MCF7; HT_HG-U133A | 8.96e-04 | 199 | 22 | 3 | 2215_DN | |
| Drug | (+/-)-blebbistatin; Down 200; 17uM; MCF7; HT_HG-U133A_EA | 8.96e-04 | 199 | 22 | 3 | 954_DN | |
| Drug | Acenocoumarol [152-72-7]; Down 200; 11.4uM; PC3; HT_HG-U133A | 8.96e-04 | 199 | 22 | 3 | 2077_DN | |
| Drug | Chloropyramine hydrochloride [6170-42-9]; Down 200; 12.2uM; HL60; HT_HG-U133A | 8.96e-04 | 199 | 22 | 3 | 3011_DN | |
| Drug | Brompheniramine maleate [980-71-2]; Down 200; 9.2uM; PC3; HT_HG-U133A | 8.96e-04 | 199 | 22 | 3 | 4013_DN | |
| Drug | Diphenylpyraline hydrochloride [132-18-3]; Down 200; 12.6uM; MCF7; HT_HG-U133A | 8.96e-04 | 199 | 22 | 3 | 4765_DN | |
| Drug | Iohexol [66108-95-0]; Up 200; 4.8uM; MCF7; HT_HG-U133A | 9.09e-04 | 200 | 22 | 3 | 3322_UP | |
| Drug | nordihydroguaiaretic acid; Up 200; 1uM; HL60; HT_HG-U133A | 9.09e-04 | 200 | 22 | 3 | 1164_UP | |
| Drug | Carteolol hydrochloride [51781-21-6]; Down 200; 12.2uM; MCF7; HT_HG-U133A | 9.09e-04 | 200 | 22 | 3 | 3276_DN | |
| Drug | Sulfathiazole [72-14-0]; Up 200; 15.6uM; MCF7; HT_HG-U133A | 9.09e-04 | 200 | 22 | 3 | 4769_UP | |
| Disease | syndromic X-linked intellectual disability Claes-Jensen type (implicated_via_orthology) | 3.18e-06 | 4 | 22 | 2 | DOID:0060809 (implicated_via_orthology) | |
| Disease | primary pulmonary hypertension (is_marker_for) | 1.48e-05 | 8 | 22 | 2 | DOID:14557 (is_marker_for) | |
| Disease | syndromic intellectual disability (implicated_via_orthology) | 6.33e-05 | 16 | 22 | 2 | DOID:0050888 (implicated_via_orthology) | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 1.92e-04 | 152 | 22 | 3 | DOID:0060041 (implicated_via_orthology) | |
| Disease | Malignant Head and Neck Neoplasm | 4.93e-04 | 44 | 22 | 2 | C0278996 | |
| Disease | high grade glioma (implicated_via_orthology) | 4.93e-04 | 44 | 22 | 2 | DOID:3070 (implicated_via_orthology) | |
| Disease | electrocardiography | 5.82e-04 | 530 | 22 | 4 | EFO_0004327 | |
| Disease | Huntington's disease (is_marker_for) | 7.15e-04 | 53 | 22 | 2 | DOID:12858 (is_marker_for) | |
| Disease | intellectual disability (implicated_via_orthology) | 1.42e-03 | 75 | 22 | 2 | DOID:1059 (implicated_via_orthology) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| SAFLGIPFAEPPMGP | 61 | P22303 | |
| MGRPAGLFPPLCPFL | 1 | Q9HB09 | |
| FLPPEPGPFPGIVDM | 211 | P49753 | |
| QMEDFFLDAPPLPPP | 111 | Q9Y2D1 | |
| LPPPEDSLFMFPCGP | 551 | O60393 | |
| SVFSPDPMPYEPCLP | 796 | P21802 | |
| FPCVPERPGMPCPGE | 106 | P41743 | |
| MEPGCDEFLPPPECP | 1 | Q9BY66 | |
| MFPVFPCTLLAPPFP | 1 | P56270 | |
| PSPPGPCMPEVFLEA | 386 | O15287 | |
| PCGFPAPLPPTRMME | 1406 | A7KAX9 | |
| TACLLGFLLPPMPPP | 106 | Q3MIN7 | |
| PLPLGFSPVCDPMDS | 81 | Q96EY5 | |
| FLAAMEPEPAPAPAP | 76 | Q14318 | |
| TAGHPEPCLMFRPPP | 76 | Q9Y226 | |
| MFCFDEVPPTPGPIA | 861 | Q9H987 | |
| DPDPAFFAAPMPGDC | 231 | Q9H6I2 | |
| DMDPPAAFSGFPALP | 6 | Q13461 | |
| MFPAPPFGLPLATLA | 276 | O60902 | |
| PQGFSGPFCEHPPPM | 1101 | O75094 | |
| AILMFPPDCPVPGPD | 651 | Q5PRF9 | |
| MEPGSDDFLPPPECP | 1 | P41229 |